3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide

C120H130Br3ClF6N20O13Zn — CID 159069172

IUPAC3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide
SMILESCC(C)(C)OC(=O)N1CCC2(CC2)C(O)C1.CC(C)(C)OC(=O)N1CCC2(CC2)C(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(-c5c(F)cccc5F)cc34)n2)C1.CC(C)(C)OC(=O)N1CCC2(CC2)C(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(Br)cc34)n2)C1.Clc1cncc(-c2nn(C3CCCCO3)c3ccc(Br)cc23)n1.Fc1[c-]c(F)ccc1.Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CNCCC45CC5)n3)c2c1.[Zn+]Br
InChIInChI=1S/C34H37F2N5O4.C28H34BrN5O4.C24H21F2N5O.C16H14BrClN4O.C12H21NO3.C6H3F2.BrH.Zn/c1-33(2,3)45-32(42)40-15-14-34(12-13-34)27(20-40)44-28-19-37-18-25(38-28)31-22-17-21(30-23(35)7-6-8-24(30)36)10-11-26(22)41(39-31)29-9-4-5-16-43-29;1-27(2,3)38-26(35)33-12-11-28(9-10-28)22(17-33)37-23-16-30-15-20(31-23)25-19-14-18(29)7-8-21(19)34(32-25)24-6-4-5-13-36-24;25-16-2-1-3-17(26)22(16)14-4-5-18-15(10-14)23(31-30-18)19-11-28-13-21(29-19)32-20-12-27-9-8-24(20)6-7-24;17-10-4-5-13-11(7-10)16(12-8-19-9-14(18)20-12)21-22(13)15-3-1-2-6-23-15;1-11(2,3)16-10(15)13-7-6-12(4-5-12)9(14)8-13;7-5-2-1-3-6(8)4-5;;/h6-8,10-11,17-19,27,29H,4-5,9,12-16,20H2,1-3H3;7-8,14-16,22,24H,4-6,9-13,17H2,1-3H3;1-5,10-11,13,20,27H,6-9,12H2,(H,30,31);4-5,7-9,15H,1-3,6H2;9,14H,4-8H2,1-3H3;1-3H;1H;/q;;;;;-1;;+2/p-1
InChIKeyOWWBHUHMIAPGSV-UHFFFAOYSA-M
MW2515.03 g/mol
LogP26.90
Rot. Bonds15

About 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide

3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide (PubChem CID 159069172) has the molecular formula C120H130Br3ClF6N20O13Zn and a molecular weight of 2515.03 g/mol. Its IUPAC name is 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide.

Molecular Properties

Compound Name3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide
PubChem CID159069172
Molecular FormulaC120H130Br3ClF6N20O13Zn
Molecular Weight2515.03 g/mol
Exact Mass2508.66
IUPAC Name3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide
SMILESCC(C)(C)OC(=O)N1CCC2(CC2)C(O)C1.CC(C)(C)OC(=O)N1CCC2(CC2)C(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(-c5c(F)cccc5F)cc34)n2)C1.CC(C)(C)OC(=O)N1CCC2(CC2)C(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(Br)cc34)n2)C1.Clc1cncc(-c2nn(C3CCCCO3)c3ccc(Br)cc23)n1.Fc1[c-]c(F)ccc1.Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CNCCC45CC5)n3)c2c1.[Zn+]Br
InChIInChI=1S/C34H37F2N5O4.C28H34BrN5O4.C24H21F2N5O.C16H14BrClN4O.C12H21NO3.C6H3F2.BrH.Zn/c1-33(2,3)45-32(42)40-15-14-34(12-13-34)27(20-40)44-28-19-37-18-25(38-28)31-22-17-21(30-23(35)7-6-8-24(30)36)10-11-26(22)41(39-31)29-9-4-5-16-43-29;1-27(2,3)38-26(35)33-12-11-28(9-10-28)22(17-33)37-23-16-30-15-20(31-23)25-19-14-18(29)7-8-21(19)34(32-25)24-6-4-5-13-36-24;25-16-2-1-3-17(26)22(16)14-4-5-18-15(10-14)23(31-30-18)19-11-28-13-21(29-19)32-20-12-27-9-8-24(20)6-7-24;17-10-4-5-13-11(7-10)16(12-8-19-9-14(18)20-12)21-22(13)15-3-1-2-6-23-15;1-11(2,3)16-10(15)13-7-6-12(4-5-12)9(14)8-13;7-5-2-1-3-6(8)4-5;;/h6-8,10-11,17-19,27,29H,4-5,9,12-16,20H2,1-3H3;7-8,14-16,22,24H,4-6,9-13,17H2,1-3H3;1-5,10-11,13,20,27H,6-9,12H2,(H,30,31);4-5,7-9,15H,1-3,6H2;9,14H,4-8H2,1-3H3;1-3H;1H;/q;;;;;-1;;+2/p-1
InChIKeyOWWBHUHMIAPGSV-UHFFFAOYSA-M
XLogP26.90
TPSA361.52 Ų
H-Bond Donors3
H-Bond Acceptors29
Rotatable Bonds15
Heavy Atoms164
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002515.03
LogP ≤ 526.90
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide?
The IUPAC name of 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide (CID 159069172) is 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide.
What is the SMILES notation for 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide?
The canonical SMILES for 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide is CC(C)(C)OC(=O)N1CCC2(CC2)C(O)C1.CC(C)(C)OC(=O)N1CCC2(CC2)C(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(-c5c(F)cccc5F)cc34)n2)C1.CC(C)(C)OC(=O)N1CCC2(CC2)C(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(Br)cc34)n2)C1.Clc1cncc(-c2nn(C3CCCCO3)c3ccc(Br)cc23)n1.Fc1[c-]c(F)ccc1.Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CNCCC45CC5)n3)c2c1.[Zn+]Br.
What is the InChIKey of 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide?
The InChIKey is OWWBHUHMIAPGSV-UHFFFAOYSA-M. The full InChI is InChI=1S/C34H37F2N5O4.C28H34BrN5O4.C24H21F2N5O.C16H14BrClN4O.C12H21NO3.C6H3F2.BrH.Zn/c1-33(2,3)45-32(42)40-15-14-34(12-13-34)27(20-40)44-28-19-37-18-25(38-28)31-22-17-21(30-23(35)7-6-8-24(30)36)10-11-26(22)41(39-31)29-9-4-5-16-43-29;1-27(2,3)38-26(35)33-12-11-28(9-10-28)22(17-33)37-23-16-30-15-20(31-23)25-19-14-18(29)7-8-21(19)34(32-25)24-6-4-5-13-36-24;25-16-2-1-3-17(26)22(16)14-4-5-18-15(10-14)23(31-30-18)19-11-28-13-21(29-19)32-20-12-27-9-8-24(20)6-7-24;17-10-4-5-13-11(7-10)16(12-8-19-9-14(18)20-12)21-22(13)15-3-1-2-6-23-15;1-11(2,3)16-10(15)13-7-6-12(4-5-12)9(14)8-13;7-5-2-1-3-6(8)4-5;;/h6-8,10-11,17-19,27,29H,4-5,9,12-16,20H2,1-3H3;7-8,14-16,22,24H,4-6,9-13,17H2,1-3H3;1-5,10-11,13,20,27H,6-9,12H2,(H,30,31);4-5,7-9,15H,1-3,6H2;9,14H,4-8H2,1-3H3;1-3H;1H;/q;;;;;-1;;+2/p-1.
What are the key properties of 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide?
3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide has a molecular weight of 2515.03 g/mol, XLogP of 26.90, 15 rotatable bonds, 3 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[6-(6-azaspiro[2.5]octan-8-yloxy)pyrazin-2-yl]-5-(2,6-difluorophenyl)-1H-indazole;5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;bromozinc(1+);tert-butyl 8-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-[6-[5-(2,6-difluorophenyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxy-6-azaspiro[2.5]octane-6-carboxylate;tert-butyl 8-hydroxy-6-azaspiro[2.5]octane-6-carboxylate;1,3-difluorobenzene-2-ide is sourced from PubChem (CID 159069172), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).